FDA Inspection 1245609 — American Red Cross Blood Services Southwest Region
The FDA completed an inspection of American Red Cross Blood Services Southwest Region on Jul 11, 2024 in Dallas, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Jul 11, 2024
- Fiscal Year
- 2024
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Dallas, TX (United States)